Three-dimensional patterns of hippocampal atrophy in mild cognitive impairment

Archives of Neurology

Volumn 63, Issue 1, 2006, Pages 97-101

  Becker, James T ^a,c   Davis, Simon W ^a   Hayashi, Kiralee M ^b   Meltzer, Carolyn Cidis ^a   Toga, Arthur W ^b   Lopez, Oscar L ^a   Thompson, Paul M ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Neuropsychological Research Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; MALE; NEUROANATOMY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SAMPLE SIZE; THREE DIMENSIONAL IMAGING;

AGED; ALZHEIMER DISEASE; ATROPHY; COGNITION DISORDERS; FEMALE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; IMAGING, THREE-DIMENSIONAL; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 30344440085     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.63.1.97     Document Type: Article

References (30)

1. Bowen J, Teri L, Kukull W, McCormick W, McCurry SM, Larson EB. Progression to dementia in patients with isolated memory loss. Lancet. 1997;349:763-765.
2. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303-308.
3. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents earlystage Alzheimer disease. Arch Neurol. 2001;58:397-405.
4. Lopez OL, Jagust WJ, DeKosky ST, et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study: part 1. Arch Neurol. 2003;60:1385-1389.
5. Gomez-Isla T, Price JL, McKeel DW, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci. 1996;16:4491-4500.
6. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl). 1991;82:239-259.
7. Pennanen C, Kivipelto M, Tuomainen S, et al. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol Aging. 2004;25:303-310.
8. Killiany RJ, Hyman BT, Gomez-Isla T, et al. MRI measures of entorhinal cortex vs hippocampus in preclinical AD. Neurology. 2002;58:1188-1196.
9. Dickerson BC, Salary DH, Bates JF, et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol. 2004;56:27-35.
10. Wu CC, Mungas D, Petkov CI, et al. Brain structure and cognition in a community sample of elderly Latinos. Neurology. 2002;59:383-391.
11. Bell-McGinty S, Lopez OL, Meltzer CC, et al. Differential cortical atrophy in subgroups of mild cognitive impairment. Arch Neurol. 2005;62:1393-1397.
12. Karas GB, Scheltens P, Rombouts SA, et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage. 2004;23:708-716.
13. Chetelat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron J-C. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport. 2002;13:1939-1943.
14. Lopez OL, Becker JT, Klunk W, et al. Research evaluation and diagnosis of possible Alzheimer's disease over the last two decades: II. Neurology. 2000;55:1863-1869.
15. Mulsant BH, Pollock BG, Nebes RD, et al. A double-blind randomized comparison of nortriptyline and paroxetine in the treatment of late-life depression: 6-week outcome. J Clin Psychiatry. 1999;60(suppl 20):16-20.
16. Lopez OL, Becker JT, Sweet RA. Non-cognitive symptoms in mild cognitive impairment subjects. Neurocase. 2005;11:65-71.
17. McKhann G, Drachman DA, Folstein MF, Katzman R, Price DL, Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
18. Duvernoy H. The Human Hippocampus: An Atlas of Applied Anatomy. Munich, Germany: JF Bergman Verlag; 1988.
19. Narr KL, Thompson PM, Sharma T, et al. Three-dimensional mapping of temporolimbic regions and the lateral ventricles in schizophrenia: gender effects. Biol Psychiatry. 2001;50:84-97.
20. Narr KL, Thompson PM, Szeszko P, et al. Regional specificity of hippocampal volume reductions in first-episode schizophrenia. Neuroimage. 2004;21:1563-1575.
21. Watson C, Andermann F, Gloor P, et al. Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging. Neurology. 1992;42:1743-1750.
22. Pantel J, Gretsinger K, Keffe H. Hippocampus tracing guidelines. Available at: http://www.psychiatry.uiowa.edu/ipl/pdf/mhcrc/papers/hippocampus. pdf. Accessed November 1, 2005.
23. Thompson PM, Schwartz C, Toga AW. High-resolution random mesh algorithms for creating a probabilistic 3D surface atlas of the human brain. Neuroimage. 1996;3:19-34.
24. Thompson PM, Schwartz C, Lin RT, Khan AA, Toga AW. 3D statistical analysis of sulcal variability in the human brain. J Neurosci. 1996;16:4261-4274.
25. Thompson PM, Hayaski KM, Sowell ER, et al. Mapping cortical changes in Alzheimer's disease, brain development, and schizophrenia. Neuroimage. 2004;23(suppl 1):S2-S18.
26. Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology. 2001;56:37-42.
27. Schroder J, Kratz B, Pantel J, Minnemann E, Lehr U, Sauer H. Prevalence of mild cognitive impairment in an elderly community sample. J Neural Transm Suppl. 1998;54:51-59.
28. Convit A, de Asis J, de Leon MJ, Tarshish CY, De Santi S, Rusinek H. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging. 2000;21:19-26.
29. Killiany RJ, Gomez-Isla T, Moss M, et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol. 2000;47:430-439.
30. Visser PJ, Scheltens P, Verhey FR, et al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol. 1999;246:477-485.